1. Home
  2. GPRE vs IMTX Comparison

GPRE vs IMTX Comparison

Compare GPRE & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

N/A

Current Price

$11.65

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Immatics N.V.

IMTX

Immatics N.V.

N/A

Current Price

$5.96

Market Cap

992.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPRE
IMTX
Founded
2004
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
992.8M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
GPRE
IMTX
Price
$11.65
$5.96
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
★ $18.67
$16.03
AVG Volume (30 Days)
★ 1.0M
976.6K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.27
N/A
Revenue
★ $2,091,680,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.15
N/A
P/E Ratio
$5.33
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.31
$5.95
52 Week High
$19.65
$12.41

Technical Indicators

Market Signals
Indicator
GPRE
IMTX
Relative Strength Index (RSI) 26.11 30.64
Support Level N/A N/A
Resistance Level $15.79 $11.82
Average True Range (ATR) 0.62 0.46
MACD -0.19 -0.03
Stochastic Oscillator 5.48 0.89

Price Performance

Historical Comparison
GPRE
IMTX

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: